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Abstract
Worldwide outbreaks of enterovirus D68 (EV-D68) in 2014 and 2016 have caused serious respiratory and neurological dis-
ease. To investigate diversity, spread, and evolution of EV-D68 we performed near full-length deep sequencing in fifty-four
samples obtained in Sweden during the 2014 and 2016 outbreaks. In most samples, intrapatient variability was low and
dominated by rare synonymous variants, but three patients showed evidence of dual infections with distinct EV-D68 var-
iants from the same subclade. Interpatient evolution showed a very strong temporal signal, with an evolutionary rate of
0.00396 0.0001 substitutions per site and year. Phylogenetic trees reconstructed from the sequences suggest that EV-D68
was introduced into Stockholm several times during the 2016 outbreak. Putative neutralization targets in the BC and DE
loops of the VP1 protein were slightly more diverse within-host and tended to undergo more frequent substitution than
other genomic regions. However, evolution in these loops did not appear to have been driven the emergence of the 2016 B3-
subclade directly from the 2014 B1-subclade. Instead, the most recent ancestor of both clades was dated to 2009. The study
provides a comprehensive description of the intra- and interpatient evolution of EV-D68, including the first report of
intrapatient diversity and dual infections. The new data along with publicly available EV-D68 sequences are included in an
interactive phylodynamic analysis on nextstrain.org/enterovirus/d68 to facilitate timely EV-D68 tracking in the future.
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1. Introduction
Enterovirus D68 (EV-D68) has been recognized as an emerging path-
ogen after recent worldwide outbreaks of serious respiratory and
neurological disease. The virus was discovered in 1962 in California,
USA in four children with pneumonia (Schieble, Fox, and Lennette
1967). Prior to 2014, EV-D68 was reported only sporadically with a to-
tal of 699 confirmed cases in Europe, Africa, and southeast Asia be-
tween 1970 and 2013 (as reviewed by Holm-Hansen, Midgley, and
Fischer 2016). But in 2014, 2,287 of cases with EV-D68 infection were
reported, mainly in North America and Europe, but also in south-
east Asia and Chile (Holm-Hansen, Midgley, and Fischer 2016).
Following the 2014 outbreak, another wave of EV-D68 infections
was observed in 2016 with reports of outbreaks in several parts of
the world, including Europe (Dyrdak et al., 2016; Barnadas et al. 2017;
Knoester et al., 2017; Piralla et al., 2018), USA (Messacar et al., 2017;
Wang et al., 2017), Argentina (Ruggieri et al., 2017), and Taiwan (Wei
et al., 2018).
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Even though EV-D68 was rarely reported before the recent
outbreaks, a high prevalence of neutralizing antibodies have
reported in samples collected before 2014 (Vogt and Crowe
2018). This indicates that infection with EV-D68 has been com-
mon also before the outbreaks in 2014 and 2016.
The main clinical presentation of EV-D68 infection is mild to
severe respiratory symptoms (Holm-Hansen, Midgley, and
Fischer 2016), but in rare cases EV-D68 can also cause a
poliomyelitis-like disease termed acute flaccid myelitis (Dyda
et al. 2018; Messacar et al. 2018). An increase of this otherwise un-
usual clinical presentation coincided with the outbreak of EV-
D68 in 2014. In animal studies, strains from 2014 were more viru-
lent than the prototype Fermon strain isolated in 1969 (Hixon,
Clarke, and Tyler, 2017; Hixon et al., 2017; Zhang et al., 2018a).
EV-D68, as other enteroviruses, has a genome size of 7.5 kb
and codes for a polyprotein, which is processed into four struc-
tural (VP1-4), and seven nonstructural proteins (2A–C, 3A–D).
Phylogenetically EV-D68 is divided into three Clades (A–C)
(Tokarz et al. 2012), and the B clade is further subdivided into
three subclades or lineages (B1–B3) (Gong et al. 2016). The 2014
and 2016 outbreaks were caused by viruses belonging to the B1
and B3 subclades, respectively (Dyrdak et al., 2016; Zhang et al.,
2016; Barnadas et al., 2017; Knoester et al., 2017; Wang et al.,
2017; Piralla et al., 2018; Wei et al., 2018). Similar to other RNA vi-
ruses, EV-D68 has been reported to have a high substitution rate
with 6.2  103 (Tokarz et al., 2012) or 5.12  103 (Ny et al., 2017)
substitutions per site per year in the highly variable VP1 gene.
Mechanisms of immune protection and immune escape for EV-
D68 are not well understood. Neutralizing antibodies have been
shown to be protective in animal models (Hixon, Clarke, and Tyler,
2017; Hixon et al., 2017; Dai et al. 2018; Zhang et al. 2018a,b). Based
on homology with the neutralizing sites NIm-IA and NIm-IB on hu-
man rhinovirus 14 (HRV-14), regions on the BC and DE loops in EV-
D68 have been proposed as putative epitopes for neutralizing anti-
bodies (Liu et al. 2015). However, also other sites in VP1 and other
proteins may be of importance. Thus, amino acid variability in
regions flanking the VP1 loops were reported to correlate with dif-
ferences in neutralization sensitivity between the prototype
Fermon strain and strains from 2014 (Zhang et al. 2015). For cox-
sackie virus B4, it was shown that a deletion in the BC loop reduced
the neutralizing effect of CVB4-specific antisera (McPhee et al. 1994).
VP2 and VP3 may also contain neutralizing epitopes as demon-
strated in early poliovirus (PV) studies (Minor et al. 1986) and as re-
cently reviewed for the enterovirus A genus (Fang and Liu 2018).
Little is known about the contribution of cellular immunity to the
clearance and evolution of EV-D68 (and other enteroviruses).
Here, we report deep sequencing of near full-length genomes
on the Illumina next-generation sequencing platform and ana-
lyze intra- and interpatient evolution of EV-D68 during the recent
outbreaks. We show that within-host diversity is typically low,
but that dual infection is not uncommon, suggesting high infec-
tion incidence during the outbreaks. To facilitate exploration of
the data and future analyses, we combined the whole-genome
sequences reported here with publicly available genomes and
implemented an interactive visualization in nextstrain available
at nextstrain.org/enterovirus/d68.
2. Materials and methods
2.1 Study population and samples
For this study we used fifty-four nasopharyngeal and five other
respiratory samples from two earlier studies on EV-D68 out-
breaks in Stockholm in 2014 and 2016 (Dyrdak et al. 2015, 2016).
The fifty-nine samples were drawn from fifty-four patients. Six
patients had been sampled in 2014, and forty-eight patients
(fifty-three samples) in 2016. Thirty of the patients were female.
The median age was 3.6 years (range 2 months–63 years). Five
patients were sampled twice during their acute illness (0, 1, 1, 2,
and 7 days apart).
All, but one, samples were submitted from hospitals in
Stockholm. However, we cannot exclude the possibility that a
few samples might be from patients who had been transferred
for care to Stockholm from other parts of Sweden.
Details about the patient demographics are given in
Supplementary Table S2.
The collection dates of the samples from the outbreak in
2016 ranged between 19 August and 13 September. The samples
had tested positive for EV-D68 at the Department of Clinical
Microbiology at Karolinska University Hospital, by EV-D68-spe-
cific realtime-PCR and/or partial VP4/VP2 sequencing. For
details see (Dyrdak et al. 2015, 2016). A few EV-D68-positive sam-
ples from the earlier studies were not included in this study be-
cause no sample material remained or because the virus levels
were very low as evaluated by the cycle threshold (Ct) values in
the EV-D68 realtime PCR. The Ct values for the included sam-
ples ranged from 13.9 to 33.9 (median 22.3). Details about the
study samples are given in Supplementary Table S3.
The study was reviewed and approved by the Regional
Ethical Review Board in Stockholm, Sweden (registration no.
2017/1317–32).
2.2 Near full-length EV-D68 amplification
Primers were designed to cover almost the entire EV-D68 genome
in four overlapping fragments (F1–F4) that were 2,000 base pairs
long (Supplementary Table S1). An alignment of published EV-
D68 genomes was used to design forward and reverse primers
targeting highly conserved regions of the EV-D68 genome, with
similar melting temperatures, and with minimal tendency for
hairpin and primer-dimer formation. Inner nested primers for
fragment F1 were designed for template quantification.
RNA was manually extracted using the RNeasy Lipid Tissue
Mini Kit (Qiagen Cat. No. 74804). For each nasopharyngeal sam-
ple, 200 ll was taken and mixed with 1 ml Qiazol, 200
ll chloroform and 5 ll carrier-RNA. After centrifugation and sev-
eral washing steps, each aliquot was eluted with 100 ll RNase-
free water and were either stored at 70C or used directly for
PCR-amplification.
Each sample was amplified in duplicate by one-step RT-PCR
for each of the four overlapping fragments. The RT-PCR mixture
contained: 11 ll of RNA template, 0.5 lM of forward and reverse
PCR primer, 1 ng/ll random hexamers, 1 ll Superscript III RT/
Platinum Taq HiFi Enzyme mix (Invitrogen, Stockholm, Sweden),
25 ll 2 reaction mix, and RNase-free water to a total volume of
50 ll. The PCR cycling profile was: 1:30 min at 50C, 2 min at
94C (cDNA synthesis); 30:15 s at 94C, 30 s at 50C, 90 s at 68C
(PCR-amplification); 1:5 min at 68C,1 at 4C (final extension).
To approximately quantify the number of input EV-D68 RNA
templates for sequencing, a dilution series of the RNA (1:10,
1:100, and 1:1,000) was amplified in duplicate with nested pri-
mers for fragment F1. EV-D68 RNA templates were enumerated
by the Poisson distribution formula. The outer PCR is described
earlier. The nested PCR mixture contained: 2.5 ll of product
from the outer PCR, 0.2 lM of forward and reverse PCR primer, 1
unit of Platinum Taq HiFi (Invitrogen, Stockholm, Sweden), 5
ll 10x reaction mix, and RNase-free water to a total volume of
50 ll. The cycling profile was: 1:2 min at 94C, (denaturation);
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30:15 s at 94C, 30 s at 50C, 90 s at 68C (PCR-amplification);
1:6 min at 68C, at 6 min (final extension).
Duplicates of each fragment were pooled and purified with
AGENCOURT AMPure XP PCR purification kit and quantified
with Qubit assays (Q32851, Life Technologies). Purified DNA
from each fragment were diluted to the same concentration,
pooled and sent to the Clinical Genomics Unit at Science for Life
Laboratory (SciLifeLab, Stockholm, Sweden) for sequencing.
2.3 DNA library preparation and sequencing
The DNA preparations were quantified using Quant-iTTM dsDNA
High-Sensitivity Assay Kit and Tecan Spark 10 M plate reader. In to-
tal 1 ll of DNA (0.5–2.0 ng/ll) was used in the tagmentation reac-
tion using Nextera chemistry (Illumina) to yield fragments >150 bp.
The tagmented library underwent eleven cycles of PCR with single-
end indexed primers (IDT Technologies) followed by purification
using Seramag beads according to the protocol. The library was
quantified using Quant-iTTM dsDNA High-Sensitivity Assay Kit
and Tecan Spark 10 M plate reader and pair-end (2  101 bp) se-
quenced to a depth of 100,000–1,000,000 reads per sample on a
HiSeq 2500 Illumina sequencer. Base calling and demultiplexing
was done using bcl2fastq v1.87, without allowing any mismatch in
the index sequence.
2.4 Quality controls experiments
Quality controls were prepared from two samples with low Ct val-
ues (SWE_027_160829 and SWE_037_160829, having Ct values
14.62 and 19.27, respectively). The samples were diluted 1:100 in a
pool of virus-negative nasopharyngeal samples and stored at
70C in 200 ll aliquots. The enterovirus RNA concentration of
the samples was quantified by limiting dilution in ten replicas of
ten-fold dilutions, from 1:10 to 1:100,000 with an in-house entero-
virus realtime-PCR (Tiveljung-Lindell et al. 2009). Based on Poisson
calculations, the samples were estimated to have 4,400 and 240
EV-D68 RNA copies per ll, respectively, prior to dilution. The two
samples were RNA extracted, PCR amplified and sequenced twice
in two separate runs. The number of EV-D68 RNA templates in
each PCR reaction was48,400 and 2,640, respectively.
2.5 Read filtering, mapping, and analysis
Sequencing reads were trimmed using TrimGalore (Martin 2011;
Krueger 2015) and mapped against the sequence KX675261.1 us-
ing bwa mem (Li and Durbin 2009). We used the pysam wrapper
to samtools to generate a pile-up of all reads and quantify inser-
tions relative to the reference. Custom python scripts were used
to generate consensus sequences and quantify intrasample di-
versity from the pile-ups. All these steps were chained using
the workflow engine snakemake (Ko¨ster and Rahmann 2012).
The entire pipeline is available github.com/neherlab/EV-
D68_analysis_Dyrdak_2019 and uses a code from a separate
project github.com/neherlab/SVVC. Commit 81068ee was used
to analyze the data along with commit a2cbb35 of SVVC. To an-
alyze linkage disequilibrium, we calculated genotype frequen-
cies p12 at pairs of positions that were covered by a read
pair more than 100-fold and calculated their correlation D12 =
p12 – p1p2 (aka linkage disequilibrium). This correlation was nor-
malized such that maximal linkage corresponds to D12 = 1 and
complete repulsion to D12 = 1.
The consensus sequences for successfully sequenced sam-
ples have been deposited in GenBank (accession numbers
MH674111–MH674166 and MH844544).
The scripts that analyze diversity in pile-ups and generate
most of the figures of this study are available at github.com/
neherlab/EV-D68_analysis_Dyrdak_2019.
2.6 Phylodynamics analysis
Sequences generated in this study were combined with sequen-
ces and metadata of all EV-D68 genomes with a length of at
least 6,000 bp available on Virus Pathogen Resource (ViPR)
(Pickett et al. 2012) as of 2 September 2018. The combined data-
set was analyzed using nextstrain (Hadfield et al. 2018) and
snakemake (Ko¨ster and Rahmann 2012). The augur pipeline was
run using the aligner MAFFT (Katoh et al. 2002), the tree-builder
(Nguyen et al. 2015), and the phylodynamic package TreeTime
(Sagulenko, Puller, and Neher 2018). The repository detailing the
analysis pipeline is available at https://github.com/neherlab/en
terovirus_nextstrain. Sub-genogrouping of sequences was done
using the Enterovirus Genotyping Tool Version 1.0 (Kroneman
et al. 2011). The resulting analysis is visualized with auspice and
is available at nextstrain.org/enterovirus/d68.
Five sequences were excluded from the phylodynamic analysis
because they were deemed problematic. The following three
sequences are within a few mutations from other sequences sam-
pled several years earlier or later: EV-D68/Homo_sapiens/USA/
U797/2007 is identical to strain EV-D68/Homo_sapiens/USA/C7791/
2014; EV_D68/Homo_sapiens/USA/O622a/2012 is very similar to
strains sampled in 2003; EV_D68/Homo_sapiens/USA/MO78/2009
is very similar to strains sampled in 2014 in the USA. Given the
high evolutionary rate of enteroviruses, such stasis over many
years is very unlikely (we expect about thirty changes per year)
and these sequences are likely dated incorrectly. The case CA/
RESP/10_786 is less clear, but the sequence is several standard
deviations less diverged from the root than expected given its col-
lection date. USA/TX/2014_19267 is likely a recombinant sequence.
Mixed effects model of evolution (MEME) analysis (Murrell
et al. 2012) using the DataMonkey package (Weaver et al. 2018)
was used to analyze for episodic diversifying selection.
3. Results
Fifty-four of fifty-nine samples yielded a coverage of at least
100 in all four fragments and were included in further analy-
ses. Of the excluded samples, two did not yield sequence in any
fragment (Ct values 30.99 and 33.89) and three samples lacked
complete sequence in one of four fragments (Ct values 20.58,
22.95, and 32.31). All five excluded samples were from 2016.
Figure 1 shows the coverage plot for a representative sample.
Figure 1. Example of coverage across the EV-D68 genome in a representative
clinical sample. Note that the coverage varies somewhat in different parts of the
genome due slightly different quantity of amplified DNA from the four overlap-
ping amplicons in the material that was used for sequencing library preparation.
The four overlapping are indicated by the horizontal gray bars.
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The sequencing coverage for each sample is presented in
Supplementary Table S3.
3.1 Reproducibility of identification of intrasample
single nucleotide variants
In addition to consensus sequences, deep population sequenc-
ing delivers information about intrasample diversity. Low ge-
nome template input, biased amplification, RT-PCR errors and
sequencing errors can all potentially skew or inflate intrasam-
ple diversity estimate (Zanini et al. 2017). To control for such
artifacts, we processed two high-titer patient samples in dupli-
cate (see Section 2.4). The accuracy of the detection and quanti-
fication of intrasample single nucleotide variants (iSNVs) was
evaluated by comparing results from the two runs (Fig. 2A).
Minor variants down to below 1 per cent were consistently
detected in both runs. Also, the estimated frequency of individ-
ual iSNVs showed good consistency between the two runs at
frequencies above 1 per cent (Panel A), but a few iSNVs had
markedly higher frequencies in one of the replicates (run 2 of
sample SWE_037).
At the majority of sites, we observed background of minor
variation at frequencies well below 0.1 per cent (see Fig. 2B).
Reproducibility of detection of iSNVs was also investigated
in the five patients were sampled twice during their acute ill-
ness (0, 1, 1, 2, and 7 days apart). Supplementary Fig. S3 shows
that frequencies of iSNVs above the 1 per cent level were largely
concordant across the two consecutive samples, especially in
patient SWE_037 (for whom the first sample was also sequenced
twice) and less so in patient SWE_012. In patient SWE_021, with
seven days between the samples, there was a tendency for an
increased variation in the second sample. Unfortunately, the
short time between the samples prevented us from estimating
the rate of intrapatient evolution or other longitudinal aspects
of intrapatient evolution of EV-D68.
Analysis of intrasample variability in all fifty-four patient
samples also provided information about our ability to detect
true biological variation. Figure 3A shows the distribution of
sites with variation above a certain frequency cutoff among
the three codon positions. The distribution was approximately
even between codon sites at very low cutoffs below 103 and
then rapidly changed around 0.3 per cent before plateauing at
1 per cent
Collectively, our results show that a majority of iSNVs at fre-
quencies >1 per cent represent true biological variation,
whereas variation <0.1 per cent mostly is due to amplification
and sequencing errors. Between 0.1 and 1 per cent an increasing
proportion of variation represents true iSNVs. The level of accu-
racy achieved is comparable to what we reported earlier for a
similar sequencing strategy for HIV-1 (Zanini et al. 2016, 2017)
and other viruses (Grubaugh et al. 2019).
3.2 Intrapatient variability
As described above intrasample variability exceeding 1 per cent
likely represents true biological variation.
Approximately 60 per cent of the variable sites above this
level occurred at the third codon position and around 30 and 10
per cent in the first and second codon positions, respectively
(see Fig. 3A). Consequently, intrapatient variability is mostly
synonymous (10, 0, and 95% of first, second, and third positions,
respectively, admit synonymous mutations in our mapping
reference).
Figure 3B shows that most (forty-four of fifty-four) samples
had fewer than ten sites that displayed variability above a level
of 3 per cent. However, three samples had more than twenty
variable sites, which suggested dual infections (see below). In
the remaining fifty-one samples, both synonymous and non-
synonymous substitutions were mostly scattered across the ge-
nome (Fig. 4). However, there was some clustering of minor var-
iation in first and second codon positions in the structural
proteins (VP4–VP1) including putative targets for neutralizing
antibodies in BC and DE loops of VP1 (Liu et al. 2015). The details
about complete amino acid substitutions and minor variation in
these regions are given in Supplementary Tables S4 and S5.
3.3 Evidence of dual infections
As mentioned earlier, three samples (SWE_007, SWE_045, and
SWE_046) drawn from three different patients showed more
than twenty iSNVs. In all three samples, most minor variants
were detected at a frequency around 10 per cent (Fig. 5, left).
This suggested the presence of two distinct variants; a major
A B
Figure 2. Accuracy of minor variant frequencies. Panel (A) shows the consistency of minor variant frequencies across two replicate extraction, RT-PCR, and sequencing
of two samples. Minor variation was relatively consistently recovered down to a frequency of about 1 per cent. Panel (B) shows the distribution of the frequencies of
non-consensus calls across all sites covered in excess of 2,000-fold. At the majority of sites, no variation above 0.001 is observed. Note that this variation includes
within sample variation, RT-PCR errors, and sequencing errors.
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variant constituting around 90 per cent of the virus population
in the sample and a minor variant constituting around 10 per
cent. To investigate the origin of these minor variants we con-
structed a ‘minor’ consensus sequence for each sample by ex-
changing the strict majority rule consensus nucleotide by the
minor variant at positions where they exceeded a frequency of
1 per cent. A phylogenetic tree analysis showed that the major
and minor sequences were monophyletic in all samples except
the three samples with indications of dual infections. For these
samples the major and minor consensus sequences occupied
different positions in the tree (see Supplementary Fig. S1). To
further investigate these putative dual infections we analyzed
the linkage of iSNVs (Fig. 5, right). Almost all iSNVs occurred in
complete linkage (LH = 1) with neighboring iSNVs, which pro-
vides strong evidence for the presence of two distinct variants,
rather than rapid evolution of intrapatient variation starting
from a single transmitted variant.
3.4 Phylodynamics of EV-D68
The interpatient evolution and phylogenetic relationship of the
EV-D68 variants from Sweden and 509 published EV-D68
sequences was investigated using the nextstrain platform avail-
able at https://nextstrain.org/enterovirus/d68 (Hadfield et al.
2018), which allows users to interactively explore the dataset. A
screen shot is displayed in Fig. 6.
The nextstrain phylodynamic analysis showed that all
Swedish EV-D68 variants from the 2016 outbreak belonged to
the B3 lineage of EV-D68, which agrees with our earlier findings
based on VP2/VP4 gene sequences (Dyrdak et al. 2016). Within
A B
Figure 3. Within sample diversity. Panel (A) shows the distribution of the number of variable sites in coding regions among different coding positions. At very low-fre-
quency cutoffs, variable sites are approximately equally distributed in codons. The distribution rapidly changes once the frequency cutoff exceeds 0.3 per cent, beyond
which variable sites are found predominantly at third codon positions and more rarely at first and second codon positions. Panel (B) shows inverse cumulative distribu-
tion of the number of samples that have more than a certain number of sites that are variable above a level of 3 per cent. Separate distributions are shown for all sites
and for first, second, and third codon position in the coding region of the genome.
Figure 4. EV-D68 intrapatient variability across the genome and codon positions. The three rows show how intrapatient variability is distributed across the EV-D68 ge-
nome for first, second, and third codon position, respectively. The panel on the left show iSNVs along the entire polypeptide, the panels on the right zoom into VP1 and
highlight the BC and DE loops. This figure includes data from one sample per patient (the first sample, for patients sampled twice), but excludes the three dual infected
samples (see main text).
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Figure 5. Minor iSNVs across the EV-D68 genome for three samples with putative dual infections. These three samples had more than twenty highly covered sites with mi-
nor variants in excess of 3 per cent frequency. On the left, iSNVs are colored by codon position or as non-coding, and given opacity depending on their frequency. The major-
ity of these variants were at third positions and had similar frequencies across the amplicons, indicated by gray bars in the lower left panel. iSNVs in three amplicons
(Amplicon 1 of sample SWE_046 and Amplicons 2 and 3 of sample SWE_007), however, were found at substantially lower frequency, possibly due to primer mismatches. The
three panels on the right are indexed by iSNV order on the genome and show linkage disequilibrium between iSNVs (>1%) close enough to each other that they were covered
at least 100-fold by the same sequencing read. Almost all of these variants at in complete linkage (dark red). A number of iSNVs just above 1 per cent in sample SWE_045 and
SWE_046 are likely variants in the background of the dominant variant. Those are in complete ‘anti-linkage’ with neighboring iSNVs are10 per cent (dark blue).
Figure 6. Phylogenetic analysis. The left panel shows a phylogenetic tree as rendered by nextstrain with the sequences labeled by region. Those from Europe, including
those from Sweden, are colored in orange. The right panel is a zoomed-in view of the boxed area on the left-hand panel colored by country and highlighting the
Swedish sequences from the 2016 outbreak (orange). Swedish sequences often cluster together, but are interspersed with sequences from Canada (dark red) and the
USA (red), implying multiple introductions that then spread locally.
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the B3 lineage our new Swedish sequences were interspersed
with international sequences, primarily from the USA, but
monophyletic clusters of Swedish sequences were also ob-
served (Fig. 6, right). A bootstrap analysis showed that most
branches were well supported (Supplementary Fig. S4).
These findings indicate that during the worldwide 2016 out-
break EV-D68 was introduced into Stockholm several times, and
that these separately introduced variants thereafter spread locally.
Interestingly, the tree indicated that the 2016 B3 subclade
did not evolve directly from the 2014 B1 subclade. Instead, the
most recent common ancestor (MRCA) of the B1 and B3 sub-
clades was estimated to have existed in first half of 2009 (90% CI
December 2008–July 2009). Many of the proximal sequences in
the B1 and B3 subclades were sampled in East Asian countries,
but this should be interpreted with caution since sampling
probably has been incomplete and geographically biased. A
tangle-tree analysis suggested recombination within subclades,
but not between clades or subclades (Supplementary Fig. S2),
but also this finding should be interpreted with caution since
there was limited intrasubclade variation.
3.5 Interpatient evolution
A plot of root-to-tip distances of EV-D68 sequences vs. time
showed an extremely strong temporal signal (Fig. 7). We esti-
mated an evolutionary rate of 3.8  103 6 104 substitutions
per site and year for the entire genome and 4.2  103 6 4 
104 for the VP1 region, which is slightly lower than previous
estimates (Tokarz et al. 2012; Ny et al. 2017). Eighty-seven per
cent of all substitutions were synonymous.
We used nextstrain to investigate diversity across the EV-
D68 genome in the sample containing the genomes reported in
this study and database genomes. Ancestral sequences were
reconstructed using the phylogeny in Fig. 6, and the number of
transition events for each codon was counted along the tree.
Figure 8 shows that amino acid substitution events were ob-
served in all EV-D68 proteins and varied between zero and
twenty-seven events per codon. The five positions with the
highest number of substitution events were: codon 234 in pro-
tein VP3 (27 events), 273 in 2C (20 events), 22 in 2A (15 events),
60 in VP3 (15 events), and 277 in 2C (14 events). None of these
positions have been reported to be neutralizing epitopes. Codon
277 in 2C and codon 1 in VP1 showed evidence of episodic diver-
sifying selection as per MEME analysis (P < 0.05).
The BC and DE loops in the VP1 protein showed relatively
high diversity, especially in positions 95, 97, 98, 142, 143, and
148, suggesting that immune selection may have impacted on
EV-D68 evolution (see Fig. 8, bottom panel, and for details see
nextstrain).
We also used nextstrain to track on which branches in the
EV-D68 phylogeny amino acid substitutions had evolved and
been fixated. The branches leading to the MRCA of the B1 and
B3 clades had many amino acid substitutions, including substi-
tutions at codons 90, 95, 97, 98, 145, and 148 in the BC and DE
loops. In contrast, no amino acid substitutions in the loops were
observed on branches separating the B1 and B3 subclades.
Similarly, only very few substitutions in the loops were ob-
served within the B1 and B3 subclades.
4. Discussion
We have performed a comprehensive investigation of the intra-
and interpatient evolution of EV-D68 using new deep near full-
length sequences from fifty-four Swedish patients sampled dur-
ing the 2014 and 2016 outbreaks and available database sequen-
ces. The new data and previously published sequences are
available on nextstrain to facilitate real-time tracking and fur-
ther study of EV-D68 evolution and spread. Intrapatient vari-
ability was mostly low and dominated by rare synonymous
substitutions, consistent with deep sequencing studies on influ-
enza virus infections (Debbink et al. 2017). However, three
patients showed evidence of dual infections. The phylodynamic
analysis indicated EV-D68 was introduced into Stockholm sev-
eral times during the 2016 outbreak and then spread locally.
Three patients showed evidence of dual infection with two
different EV-D68 variants. Even though co-infections with dif-
ferent enteroviruses has been reported for PV and non-polio
enteroviruses (Melnick et al. 1951; Parks et al. 1967; Isaacs et al.
2018), this is to our knowledge the first report of dual infections
with EV-D68. Dual infections during the 2016 outbreak are not
completely surprising in view of the high EV-D68 incidence dur-
ing the outbreak (Dyrdak et al. 2016) and the fact that the pre-
sent study showed multiple introductions of the B3 subclade
Figure 8. Interpatient diversity of EV-D68. Amino acid substitution events on the
phylogeny in Fig. 6 left were enumerated using nextstrain. Top panel shows the
number of such events for each codon along the entire coding sequence. Bottom
panel shows events in VP1, where peaks were observed in the BC and DE loops,
as well as both ends of the protein.
Figure 7. Temporal signal. A scatter plot of root-to-tip distance vs. time indicates
an extremely strong temporal signal with an evolutionary rate of l ¼ 0.0039 6
0.0001 substitutions per site and year.
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into Stockholm. We also found indications of intrasubclade re-
combination, but not between clades or subclades. Similar find-
ings have been reported in three recent studies (Tan et al. 2015;
Ny et al. 2017; Yip et al. 2017). It is expected that recombination
primarily would occur within subclades since recombination
requires co-infection with two or more virus variants and EV-
D68 variants that circulate during an outbreak or season tend to
be closely related.
The EV-D68 genome was amplified in four overlapping
amplicons that were sequenced on the Illumina HiSeq platform.
Our results indicate that variation down to a frequency of 1 per
cent represented ‘true’ iSNVs, which were reproducibly detected
and quantified. In contrast, most variation below 0.1 per cent
represented noise from cDNA synthesis, PCR and sequencing. It
would be interesting to compare the performance of our se-
quencing protocol with the pan-enterovirus protocol recently
published by (Isaacs et al. 2018). In the fifty-four samples that
were sequenced to sufficient depth we observed that most
nucleotides were conserved. Among iSNVs detected above the 1
per cent level, most occurred at the third codon position, that is,
were usually synonymous. The finding that intrapatient varia-
tion was limited and mostly synonymous was expected since
infection usually appeared to have been established by a single
virion and EV-D68 is an acute infection where is limited time for
the virus to diversify within the infected host.
Albeit there is a bias introduced by sampling and typing be-
ing done only at certain centras, the phylodynamic analysis
showed that the splits between EV-D68 clades and subclades oc-
curred several years ago. For instance, the MRCA of the B1 and
B3 subclades was estimated to have existed in 2009. Enterovirus
infections, like influenza, has a seasonal pattern. However, in
contrast to influenza, which infects people of all age groups and
has a ladder-like phylogenetic pattern that indicates a strong
immune selection, EV-D68 infects predominantly children, and
its phylogenetic pattern does not suggest continuous immune
escape (Grenfell et al. 2004). In line with this, the branches lead-
ing to the B1 and B3 subclades did not have amino acid substitu-
tions in the BC and DC loops, which are putative targets for
neutralizing antibodies. However, it should be acknowledged
that there is limited knowledge about targets for humoral and
cellular immunity in EV-D68.
Our phylodynamic analysis suggested that the recent
global outbreaks of EV-D68 might have been preceded by low-
level circulation of EV-D68 in East Asia. However, this pattern
should be interpreted with much caution since the number of
available full-length EV-D68 sequences is low and the sequen-
ces have not been systematically collected in time or space.
We hope that the nextstrain platform will allow for
continuous collection and sharing of EV-D68 sequence data,
which will be needed to obtain a better understanding of how
new successful EV-D68 variants evolve and spread. Better
knowledge about humoral and cellular immunity against EV-
D68 is also needed.
Supplementary data
Supplementary data are available at Virus Evolution online.
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